Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29, p.viii410-viii410 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | viii410 |
|---|---|
| container_issue | |
| container_start_page | viii410 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Glisson, B. Leidner, R. Ferris, R.L. Powderly, J. Rizvi, N.A. Keam, B. Schneider, R. Goel, S. Ohr, J.P. Zheng, Y. Eck, S. Gribbin, M. Townsley, D.M. Chiou, V. Patel, S.P. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy288.025 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy288_025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419496099</els_id><sourcerecordid>32137028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2785-17279ec4ada1e20209255c85b56c9beac1481c9bb719abee70987c57b3b7cd603</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EgvLzAFyQH6ChthPHsTghfiuBegAkbtHGdqlRYlexW1TOPDiuAhw57Wo1M9r5EDql5JwSmU_AOe_UpNMbVlXnhPEdNKK8lFlFCrqLRkSyPBM8Lw7QYQjvhJBSMrmPDnJGc0FYNUJfTzA3cYPBaaxa66yCFoOKdm3T1c_x4831lPCSjTHgxaoDZz-NxrPXgmB4886GiDvvvGq92zpdtI3XmzG2DoNetREvIVrjYsAfNi7SbQ1OpYTgW6txXHW-D8dobw5tMCc_8wi93N48X91nD7O76dXlQ6aYqHhGBRPSqAI0UMMIS_U4VxVveKlkY0DRoqJpawSV0BgjiKyE4qLJG6F0SfIjRIdc1fsQejOvl73toN_UlNRbovVAtB6I1olo8pwNnuWq6Yz-c_wiTIKLQWDS52tr-jqoVDh1tL1Rsdbe_hP_DZB2ijA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Glisson, B. ; Leidner, R. ; Ferris, R.L. ; Powderly, J. ; Rizvi, N.A. ; Keam, B. ; Schneider, R. ; Goel, S. ; Ohr, J.P. ; Zheng, Y. ; Eck, S. ; Gribbin, M. ; Townsley, D.M. ; Chiou, V. ; Patel, S.P.</creator><creatorcontrib>Glisson, B. ; Leidner, R. ; Ferris, R.L. ; Powderly, J. ; Rizvi, N.A. ; Keam, B. ; Schneider, R. ; Goel, S. ; Ohr, J.P. ; Zheng, Y. ; Eck, S. ; Gribbin, M. ; Townsley, D.M. ; Chiou, V. ; Patel, S.P.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy288.025</identifier><identifier>PMID: 32137028</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii410-viii410</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2785-17279ec4ada1e20209255c85b56c9beac1481c9bb719abee70987c57b3b7cd603</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glisson, B.</creatorcontrib><creatorcontrib>Leidner, R.</creatorcontrib><creatorcontrib>Ferris, R.L.</creatorcontrib><creatorcontrib>Powderly, J.</creatorcontrib><creatorcontrib>Rizvi, N.A.</creatorcontrib><creatorcontrib>Keam, B.</creatorcontrib><creatorcontrib>Schneider, R.</creatorcontrib><creatorcontrib>Goel, S.</creatorcontrib><creatorcontrib>Ohr, J.P.</creatorcontrib><creatorcontrib>Zheng, Y.</creatorcontrib><creatorcontrib>Eck, S.</creatorcontrib><creatorcontrib>Gribbin, M.</creatorcontrib><creatorcontrib>Townsley, D.M.</creatorcontrib><creatorcontrib>Chiou, V.</creatorcontrib><creatorcontrib>Patel, S.P.</creatorcontrib><title>Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQhC0EgvLzAFyQH6ChthPHsTghfiuBegAkbtHGdqlRYlexW1TOPDiuAhw57Wo1M9r5EDql5JwSmU_AOe_UpNMbVlXnhPEdNKK8lFlFCrqLRkSyPBM8Lw7QYQjvhJBSMrmPDnJGc0FYNUJfTzA3cYPBaaxa66yCFoOKdm3T1c_x4831lPCSjTHgxaoDZz-NxrPXgmB4886GiDvvvGq92zpdtI3XmzG2DoNetREvIVrjYsAfNi7SbQ1OpYTgW6txXHW-D8dobw5tMCc_8wi93N48X91nD7O76dXlQ6aYqHhGBRPSqAI0UMMIS_U4VxVveKlkY0DRoqJpawSV0BgjiKyE4qLJG6F0SfIjRIdc1fsQejOvl73toN_UlNRbovVAtB6I1olo8pwNnuWq6Yz-c_wiTIKLQWDS52tr-jqoVDh1tL1Rsdbe_hP_DZB2ijA</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Glisson, B.</creator><creator>Leidner, R.</creator><creator>Ferris, R.L.</creator><creator>Powderly, J.</creator><creator>Rizvi, N.A.</creator><creator>Keam, B.</creator><creator>Schneider, R.</creator><creator>Goel, S.</creator><creator>Ohr, J.P.</creator><creator>Zheng, Y.</creator><creator>Eck, S.</creator><creator>Gribbin, M.</creator><creator>Townsley, D.M.</creator><creator>Chiou, V.</creator><creator>Patel, S.P.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors</title><author>Glisson, B. ; Leidner, R. ; Ferris, R.L. ; Powderly, J. ; Rizvi, N.A. ; Keam, B. ; Schneider, R. ; Goel, S. ; Ohr, J.P. ; Zheng, Y. ; Eck, S. ; Gribbin, M. ; Townsley, D.M. ; Chiou, V. ; Patel, S.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2785-17279ec4ada1e20209255c85b56c9beac1481c9bb719abee70987c57b3b7cd603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glisson, B.</creatorcontrib><creatorcontrib>Leidner, R.</creatorcontrib><creatorcontrib>Ferris, R.L.</creatorcontrib><creatorcontrib>Powderly, J.</creatorcontrib><creatorcontrib>Rizvi, N.A.</creatorcontrib><creatorcontrib>Keam, B.</creatorcontrib><creatorcontrib>Schneider, R.</creatorcontrib><creatorcontrib>Goel, S.</creatorcontrib><creatorcontrib>Ohr, J.P.</creatorcontrib><creatorcontrib>Zheng, Y.</creatorcontrib><creatorcontrib>Eck, S.</creatorcontrib><creatorcontrib>Gribbin, M.</creatorcontrib><creatorcontrib>Townsley, D.M.</creatorcontrib><creatorcontrib>Chiou, V.</creatorcontrib><creatorcontrib>Patel, S.P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glisson, B.</au><au>Leidner, R.</au><au>Ferris, R.L.</au><au>Powderly, J.</au><au>Rizvi, N.A.</au><au>Keam, B.</au><au>Schneider, R.</au><au>Goel, S.</au><au>Ohr, J.P.</au><au>Zheng, Y.</au><au>Eck, S.</au><au>Gribbin, M.</au><au>Townsley, D.M.</au><au>Chiou, V.</au><au>Patel, S.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii410</spage><epage>viii410</epage><pages>viii410-viii410</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137028</pmid><doi>10.1093/annonc/mdy288.025</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29, p.viii410-viii410 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy288_025 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Safety and clinical activity of MEDI0562, a humanized OX40 agonist monoclonal antibody, in adult patients with advanced solid tumors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T09%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20and%20clinical%20activity%20of%20MEDI0562,%20a%20humanized%20OX40%20agonist%20monoclonal%20antibody,%20in%20adult%20patients%20with%20advanced%20solid%20tumors&rft.jtitle=Annals%20of%20oncology&rft.au=Glisson,%20B.&rft.date=2018-10&rft.volume=29&rft.spage=viii410&rft.epage=viii410&rft.pages=viii410-viii410&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy288.025&rft_dat=%3Cpubmed_cross%3E32137028%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137028&rft_els_id=S0923753419496099&rfr_iscdi=true |